I had trimmed RMD from CG/B due to it being ahead of itself and a little expensive. I am a buyer of a dip. The company reported weak sales and EPS that missed but by a lot less than one might have expected giving the sales shortfall. Sales were hurt by Japan and by masks in the U.S. Japan is a short-term situation, while the U.S. is more questionable. I think that the company is probably right - the U.S. is just a short-term issue related to both the timing of new products as well as reimbursement issues related to competitive bidding.
I recently raised my target by lifting the PE from 20 to 21. This is an art, but I actually think that the PE could rise more over time. Based on slightly lower earnings outlook I expect, my target drops to 66 from 68. I like this stock near 50 and love it 46-48.